Synonym | Cell Type | QPCR Expression | Normalized To | Data From |
---|
Nfe2 | LSK- | -1.74 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | LSK- | -1.72 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | LSK- | -1.6 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
. | | | | |
Nfe2 | LSK+ | -1.85 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | LSK+ | -1.68 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | LSK+ | -1.77 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
. | | | | |
Nfe2 | PreM | -1.32 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | PreM | -1.33 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | PreM | -1.35 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
. | | | | |
Nfe2 | ProB | -1.62 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | ProB | -1.74 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | ProB | -1.8 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
. | | | | |
Nfe2 | ProT | -1.64 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | ProT | -1.85 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Nfe2 | ProT | -1.8 | GAPD | LSK vs ProT, ProB and pre-myeloid expressions (Tydell et al. 2007, The Journal of Immunology) |
Synonym | Perturbation | QPCR Expression | Relative To | Data From |
---|
Nfe2 | BM | 0.31 | Thymus | GATA-3 Expression, Other Tissues (Taghon et al. 2007 Nat. Immunol) |
Nfe2 | Mast | 0.46 | Thymus | GATA-3 Expression, Other Tissues (Taghon et al. 2007 Nat. Immunol) |
Nfe2 | Fthymus | 0.22 | Thymus | GATA-3 Expression, Other Tissues (Taghon et al. 2007 Nat. Immunol) |
. | | | | |
Nfe2 | LZ_DL | 0 | LZ,DL | Notch-Delta interaction data (Taghon et al. 2007 Nat. Immunol) |
Nfe2 | LZ_noDL | 0 | LZ,DL | Notch-Delta interaction data (Taghon et al. 2007 Nat. Immunol) |
. | | | | |
Nfe2 | LZ_DL | 0 | LZ,DL | Over Expressed GATA-3 (Taghon et al. 2007 Nat. Immunol) |
Nfe2 | G3_DL | 0 | LZ,DL | Over Expressed GATA-3 (Taghon et al. 2007 Nat. Immunol) |
Nfe2 | KRRm_DL | 0.06 | LZ,DL | Over Expressed GATA-3 (Taghon et al. 2007 Nat. Immunol) |
Nfe2 | LZ_noDL | 0 | LZ,DL | Over Expressed GATA-3 (Taghon et al. 2007 Nat. Immunol) |
Nfe2 | G3_noDL | -0.04 | LZ,DL | Over Expressed GATA-3 (Taghon et al. 2007 Nat. Immunol) |
Nfe2 | KRRm_noDL | -0.1 | LZ,DL | Over Expressed GATA-3 (Taghon et al. 2007 Nat. Immunol) |